Search

According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.

… Wednesday, June 24, 2020 Background Mini Kamboj, MD Mini Kamboj, MD Ying Taur, MD, PhD Ying Taur, MD, PhD The characterization of COVID-19 in patients with cancer remains limited in published studies and nationwide surveillance analyses. Reports from China and Italy have raised the possibility that patients

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.

… Monday, August 11, 2025 According to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK), a new vaccine shows encouraging early results as a potential “off-the-shelf” treatment for patients with  pancreatic  or  colorectal cancer . Unlike individualized cancer vaccines, which

Lea sobre una vacuna terapéutica que podría ayudar a prevenir que ciertos casos de cáncer de páncreas y colorrectal vuelvan a aparecer.

… Monday, August 11, 2025 Según un estudio codirigido por investigadores del Memorial Sloan Kettering Cancer Center (MSK), una nueva vacuna muestra resultados iniciales prometedores como posible tratamiento ‘listo para usar’ para pacientes con cáncer de páncreas  o  colorrectal . A diferencia de las vacunas

Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.

… Monday, January 14, 2019 Oncologic outcomes are similar with the use of a sentinel lymph node (SLN) algorithm compared to performing a full pelvic and paraaortic lymph node dissection (LND) in node-negative patients with deeply invasive endometroid endometrial carcinoma (EEC), according to our recent

… Wednesday, May 2, 2018 Summary This story originally appeared in Bridges, our newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to receive

Given the current pandemic, every time a healthcare provider asks a patient to come in for an appointment, they’re making a mental calculation of the risk and benefit. Utilizing telemedicine has allowed providers at Memorial Sloan Kettering (MSK) to keep patients safely sheltered at home, while continuing to provide their necessary care.

… Thursday, May 7, 2020 Going through treatment for cancer is almost like having a fulltime job. Patients can have multiple appointments, and it is not uncommon for some patients to have three or more visits a week. Given the current pandemic, every time a healthcare provider asks a patient to come in

Get to know Marissa Gredler, a postdoctoral fellow in the Sloan Kettering Institute.

… Friday, March 27, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Marissa Gredler is a postdoctoral fellow in the Zallen lab  in the Sloan Kettering Institute. When and how did

An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.

… Wednesday, July 13, 2022 When Kate Delp was diagnosed with stage 2 breast cancer , she faced a decision: Should she have a lumpectomy or a mastectomy ? “From what I’d heard about mastectomy, I knew that it was a very invasive surgery and difficult to go through,” says Kate, who lives in New Jersey and

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.

… Wednesday, March 29, 2023 Highlights MSK researchers identified a key role for the STING signaling pathway in preventing dormant metastatic cancer cells from progressing to active metastases. Treating laboratory mice with a STING activator helped eliminate lingering metastatic cells and stop the development

An innovative technique called stereotactic hypofractionated accelerated radiation to the prostate – aka SHARP - safely and effectively delivers powerful doses of radiation directly to the patient’s tumor with incredible precision.

… Friday, June 2, 2017 For decades, experts at Memorial Sloan Kettering have been pioneering sophisticated ways to safely and effectively deliver powerful doses of radiation directly to a person’s tumor with incredible precision. One recent example of these ongoing efforts is an innovative technique called